Scientists use machine learning to predict major clinical forms of drug cardiotoxicity
Digital toolkit launched to encourage digital collaboration in pharma R&D
Soleno Plunging 48% In Pre-Market On Obesity Study Failure
Watchdog Aims for Speedy Remdesivir Approval
AZ reportedly mulls biggest-ever pharma merger with Gilead
Oxford Biomedica Clinches Manufacturing Deal For AstraZeneca’s Covid-19 Vaccine
Junshi Biosciences Kicks Off China’s First Covid-19 Antibody Trial
AstraZeneca Approached Gilead For Potential Merger - Report
AbbVie Announces Partnership To Develop Novel Covid-19 Antibody Therapy
Goldman Sachs: These 2 Stocks Are Poised to Surge by at Least 30%
AstraZeneca blood cancer drug shows signs of helping COVID-19 patients
iBio – IBIO-201
Hot shots named in Trump’s Warp Speed drive for coronavirus vaccine
Novavax Surging On $60M Funding For Covid-19 Vaccine Candidate
Inovio Suing Suppliers Over Covid-19 Vaccine Production
AstraZeneca Partners With Accent To Develop Novel Cancer Treatments
COVID-19 driving adoption of virtual trials
5 Promising Covid-19 Vaccines Picked For Trump’s Operation Warp Speed
Scientists tap the world's most powerful computers in the race to understand and stop the coronavirus
LabCorp Launches Website to Connect Patients with COVID-19 Clinical Trials
Study panning anti-malaria drug Trump took against COVID faces new questions
HCQ Misinformation Can Be Deadly: Let Patients Decide
Study finds COVID-19 convalescent plasma therapy safe, with 76% patients improving
Antibody injections could fight COVID-19 infections – an infectious disease expert explains the prospects
From the research lab to your doctor's office – here's what happens in phase 1, 2, 3 drug trials
Convenient spit test helps women assess cancer risk from the comfort of their own homes
Drugmaker Abbvie Teams Up With Jacobio To Develop Cancer Inhibitor
Exclusive: Sanofi stops enrolling COVID-19 patients in hydroxychloroquine trials
How the coronavirus could be prevented from invading a host cell
Atriva takes MEK inhibitor into phase 2 for COVID-19